Treating Autoimmune Pain Disorders with Body-Feedback Acupuncture, Essential Oils, and Herbs

CONTINUING EDUCATION CREDITS:
8 CEU/PDA/CPD accepted by CA #383 (Category 1), NCCAOM (7 AOM-OM/1 PE-CW), FL (General), IL, TX (4 Herbology, 4 General), AHPRA, AFPA, BAcC, CTCMA, IVAS, NZASA, NZRA

COURSE TYPE:
Distance Learning CEU Video (Online)

COURSE DESCRIPTION:
Autoimmune pain disorders are conditions that occur when the body’s immune system mistakenly attacks its own tissues, resulting in the sensation of pain. In this course, Michelle Meramour shares how she has successfully treated autoimmune pain disorders using an integration of palpation-based acupuncture, Chinese herbs, supplements, and essential oils.

The autoimmune pain disorders covered in this class include rheumatoid arthritis, lupus, and fibromyalgia. Participants will first learn the allopathic and TCM pathogenesis of each autoimmune pain disorder. Next, Michelle will share Body-Feedback palpation methods for evaluating organ dysfunction and meridian imbalances affecting the immune and pain systems. And finally, Michelle shares how she successfully treats these conditions using an integration of palpation-based acupuncture, Chinese herbs, supplements, and essential oils. Case studies and understanding fundamental laboratory test values associated with pain and immune health will also be covered.

Upon completion of this course, practitioners will:

• Gain a better understanding of autoimmune pain disorders though TCM differential diagnosis
• Learn palpation-based techniques to assess and identify organs associated with autoimmune pain conditions
• Learn classical five-element point prescriptions to support and improve the immune system
• Learn palpation techniques to muscle-test Chinese herbal formulas, nutritional supplements, and essential oils to manage immune dysfunction to the meridian system

CANCELLATION POLICY:
These online courses are immediately accessible after purchase therefore are non-refundable.

For more info on Online Videos, click here [1] to visit our FAQ page.